Innovative Industrial Properties (IIPR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Nov, 2025Executive summary
Generated Q1 2025 revenues of $71.7 million and AFFO of $55.3 million, with net income attributable to common stockholders of $30.3 million, and ended with over $220 million in liquidity.
Q1 2025 was marked by tenant defaults (PharmaCann, 4Front, Gold Flora, TILT), leading to lease defaults, application of $5.8 million in security deposits for rent, and a strategic tenant refresh initiative.
Repurchased 371,538 shares of common stock for $20.1 million and retired nearly $9 million of debt at a discount.
Acquired a $7.8 million Maryland facility, sold a Michigan facility for $9 million, and executed two new leases totaling 211,000 sq ft.
Owns 110 properties in 19 states, with 98.4% leased as of March 31, 2025, and a weighted-average lease term of 13.5 years.
Financial highlights
Q1 2025 revenues were $71.7 million, down 6.5% sequentially and 5% year-over-year, mainly due to tenant defaults and property sales.
AFFO was $55.3 million ($1.94 per share), down 13% from Q4 2024 and 12% year-over-year.
Net income attributable to common stockholders was $30.3 million, down from $39.1 million in Q1 2024.
Cash flows from operations were $54.2 million, down from $71.6 million in Q1 2024.
Declared dividends: $1.90 per common share and $0.5625 per Series A preferred share.
Outlook and guidance
Management expects the tenant refresh and retenting process to continue over the next 18–36 months, with ongoing challenges from tenant financial health and regulatory uncertainty.
Confident in the ability to stabilize the portfolio and capitalize on new investment opportunities within 3–6 months.
Liquidity expected to be sufficient through cash on hand, operations, and available credit.
Three properties re-leased with rent commencement contingent on tenant approvals; no rental revenue expected until approvals are obtained.
Ongoing tenant replacement initiative to improve credit quality and long-term portfolio performance.
Latest events from Innovative Industrial Properties
- 2025 revenues hit $266M; life sciences investment and leasing drive growth amid tenant challenges.IIPR
Q4 202524 Feb 2026 - Q2 revenue up 4% to $79.8M, AFFO $2.29/share, 95.6% leased, and dividend up 4.4%.IIPR
Q2 20242 Feb 2026 - Q3 2024 revenue was $76.5M, AFFO $64.3M, and portfolio was 95.7% leased.IIPR
Q3 202415 Jan 2026 - 2024 revenue steady at $308.5M; strong liquidity, high occupancy, and PharmaCann lease resolution.IIPR
Q4 202423 Dec 2025 - 2024 saw record revenue, strong governance, and enhanced ESG and compensation practices.IIPR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, and executive pay, with board support for all.IIPR
Proxy Filing1 Dec 2025 - Q2 2025 revenue and AFFO fell sharply, but liquidity is strong and IQHQ investment boosts outlook.IIPR
Q2 202523 Nov 2025 - Q3 2025 revenue fell 15% to $64.7M as tenant defaults hit, but life sciences diversification advanced.IIPR
Q3 202513 Nov 2025 - Diversified cannabis real estate portfolio drives growth and strong shareholder returns.IIPR
Investor Presentation14 Oct 2025